"parapet"

#12091303

24 February 2025

Ioannis Papapetrou of Panathinaikos AKTOR Athens stands before the Turkish Airlines EuroLeague Regular Season Round 21 match between FC Barcelona and Panathinaikos AKTOR Athens at Palau Blaugrana in Barcelona, Spain, on January 15, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12091307

24 February 2025

Ioannis Papapetrou of Panathinaikos AKTOR Athens stands before the Turkish Airlines EuroLeague Regular Season Round 21 match between FC Barcelona and Panathinaikos AKTOR Athens at Palau Blaugrana in Barcelona, Spain, on January 15, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12091308

24 February 2025

Ioannis Papapetrou of Panathinaikos AKTOR Athens stands before the Turkish Airlines EuroLeague Regular Season Round 21 match between FC Barcelona and Panathinaikos AKTOR Athens at Palau Blaugrana in Barcelona, Spain, on January 15, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12091355

24 February 2025

Chimezie Metu, #10 of FC Barcelona, and Ioannis Papapetrou of Panathinaikos AKTOR Athens, #77, are in action during the Turkish Airlines EuroLeague Regular Season Round 21 match between FC Barcelona and Panathinaikos AKTOR Athens at Palau Blaugrana in Barcelona, Spain, on January 15, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12025151

6 February 2025

Ioannis Papapetrou of Panathinaikos AKTOR Athens plays during the Euroleague, Round 26 match between Panathinaikos AKTOR Athens and Anadolu Efes at OAKA Altion Arena in Athens, Greece, on February 6, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#12025134

6 February 2025

Kendrick Nunn of Panathinaikos AKTOR Athens celebrates with his teammates during the Euroleague, Round 26 match between Panathinaikos AKTOR Athens and Anadolu Efes at OAKA Altion Arena in Athens, Greece, on February 6, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11976348

24 January 2025

Ioannis Papapetrou of Panathinaikos AKTOR Athens plays during the Euroleague, Round 23 match between Panathinaikos AKTOR Athens and Zalgiris Kaunas at OAKA Altion Arena in Athens, Greece, on January 23, 2025.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950561

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950562

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950563

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950564

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950565

16 January 2025

A desk filled with documents during the testing of the new AILIS machine as part of clinical trials aimed at detecting breast cancer, in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. Using Parametric Dynamic Imaging (PDI) and artificial intelligence, it can distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials are currently conducted in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950566

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950567

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950572

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#11950573

16 January 2025

The new AILIS machine tests for breast cancer detection during a clinical trial in Krakow, Poland, on December 30, 2024. AILIS is an innovative approach to breast cancer detection, developed by Michal Matuszewski. It uses Parametric Dynamic Imaging (PDI) and artificial intelligence to distinguish areas of increased activity from normal tissue, enabling the identification of cancerous lesions. Clinical trials currently take place in collaboration with the National Oncology Institute in Krakow. Upon successful results, the technology is expected to enter the Polish market first, followed by expansion into Europe. Poland has the highest breast cancer mortality rate in the EU, with early-stage detection standing at only 41%.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.